Randomized, Placebo-Controlled Trial of Paroxetine Versus Imipramine in Depressed HIV-Positive Outpatients
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study examined whether a selective serotonin reuptake inhibitor (paroxetine) had comparable efficacy but greater tolerability than a tricyclic antidepressant (imipramine) in depressed patients with HIV infection. METHOD: Seventy-five HIV-positive patients (45% of whom had AIDS) were blindly and randomly assigned to receive paroxetine (N = 25), imipramine (N = 25), or placebo (N = 25) in a 12-week trial. The Hamilton Anxiety Rating Scale, the Hamilton Depression Rating Scale, the Clinical Global Impression scale, and the SAFETEE general inquiry (for safety and tolerability) were administered at weeks 2, 4, 6, 8, and 12. RESULTS: Fifty-six (75%) of the 75 patients completed 6 weeks and 34 (45%) completed 12 weeks of the trial. The mean daily doses of both paroxetine (33.9 mg) and imipramine (162.5 mg) were significantly more effective than placebo; they were comparably effective at weeks 6, 8, and 12 according to the intent-to-treat analysis and at week 8 according to the analysis for the subjects who completed the trial (for them, only imipramine was superior to placebo at week 12). There were significantly more dropouts due to side effects from imipramine (48%) than from both paroxetine (20%) and placebo (24%). CONCLUSIONS: Depressed patients with HIV infection responded to imipramine or paroxetine at a higher rate than to placebo irrespective of severity of immunosuppression. Because paroxetine was much better tolerated than imipramine, its overall effectiveness may be greater. However, because of the small study group and the high attrition rate, these findings cannot be generalized and may need replication in a larger study group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The brief symptom inventory: an introductory report.
Derogatis, L. R., & Melisaratos, N. (1983) · Psychological Medicine · doi:10.1017/s0033291700048017 · Cited by 6,650
Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites
Robins, L. N. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210031005 · Cited by 2,550 · cited 1×
“While depressionlike syndromes are difficult to diagnose in the context of medical illness, these rates are elevated in comparison with estimates in two community samples (9, 10) of lifetime diagnoses (5% and 17%, respectively) and current diagnoses (3% and 10%, respectively) of major depression.”
ResultFrank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 1×
“We defined partial response as a 50% decrease in Hamilton depression score (at week 12) from baseline and full response as a Hamilton depression score of less than 8 (35).”
Method
Cited by
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Ickovics, J. R., Hamburger, M. E., Vlahov, D., Schoenbaum, E. E., Schuman, P., Boland, R. J., Moore, J., & for the HIV Epidemiology Research Study Group (2001) · JAMA · doi:10.1001/jama.285.11.1466 · Cited by 889
Bourin, M., Chue, P., & Guillon, Y. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00189.x · Cited by 408
Assessing and Managing Depression in the Terminally Ill Patient
Block, S. D., & Panel, F. T. A.-A. E.-O.-L. C. C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-3-200002010-00007 · Cited by 384
HIV and Depression – a systematic review of interventions
Sherr, L., Clucas, C., Harding, R., Sibley, E., & Catalan, J. (2011) · Psychology, Health & Medicine · doi:10.1080/13548506.2011.579990 · Cited by 325
“Of these, we found several publications that reported on the same study: Sikkema et al. (2004), Smith et al. (2009), Markowitz et al. (1995, 1998, 2000), Carrico et al. (2006), Antoni et al. (2000, 2005, 2006), Elliott et al. (1998, 2000), Lutgendorf et al. (1997, 1998).”
BackgroundResultInfluentialComorbidity of depression with other medical diseases in the elderly
Krishnan, K. R. R., Delong, M., Kraemer, H., Carney, R., Spiegel, D., Gordon, C., McDonald, W., Dew, M. A., Alexopoulos, G., Buckwalter, K., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01472-5 · Cited by 290
Paroxetine: An Update of Its Use in Psychiatric Disorders in Adults
Wagstaff, A. J., Cheer, S. M., Matheson, A. J., Ormrod, D., & Goa, K. L. (2002) · Drugs · doi:10.2165/00003495-200262040-00010 · Cited by 287
Horberg, M. A., Silverberg, M. J., Hurley, L. B., Towner, W. J., Klein, D. B., Bersoff-Matcha, S., Weinberg, W. G., Antoniskis, D., Mogyoros, M., Dodge, W. T., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318160d53e · Cited by 264
Gartlehner, G., Gaynes, B. N., Hansen, R. A., Thieda, P., DeVeaugh-Geiss, A., Krebs, E. E., Moore, C. G., Morgan, L., & Lohr, K. N. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00008 · Cited by 237
Neuropsychiatric manifestations of HIV infection and AIDS
Dubé, B., Benton, T., Cruess, D. G., & Evans, D. L. (2005) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0533 · Cited by 210
Ramasubbu, R., Taylor, V. H., Samaan, Z., Sockalingham, S., Li, M., Patten, S., Rodin, G., Schaffer, A., Beaulieu, S., & McIntyre, R. S. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400110 · Cited by 206
Psychological Issues in End-of-Life Care
Block, S. D. (2006) · Journal of Palliative Medicine · doi:10.1089/jpm.2006.9.751 · Cited by 171
Rayner, L., Price, A., Evans, A., Valsraj, K., Hotopf, M., & Higginson, I. J. (2011) · Palliative Medicine · doi:10.1177/0269216310380764 · Cited by 170
Medical Co-Morbidity in Depressive Disorders
Benton, T., Staab, J., & Evans, D. L. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701653542 · Cited by 164
A systematic review of interventions for anxiety in people with HIV
Clucas, C., Sibley, E., Harding, R., Liu, L., Catalan, J., & Sherr, L. (2011) · Psychology, Health & Medicine · doi:10.1080/13548506.2011.579989 · Cited by 81
Prevalence, impact, and management of depression and anxiety in patients with HIV: a review
Chaudhury, S., Bakhla, A., & Saini, R. (2016) · Neurobehavioral HIV Medicine · doi:10.2147/nbhiv.s68956 · Cited by 54
“152 Considering the fact that dry mouth is a frequent complaint among PLWHA, 154 TCAs should be used in this population with caution.”
Metadata
- Authors
- Elliott, A. J., Uldall, K. K., Bergam, K., Russo, J., Claypoole, K., & Roy-Byrne, P. P.
- Venue
- American Journal of Psychiatry
- Published
- 1998-03-01
- Volume
- 155
- Issue
- 3
- Pages
- 367-372
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W1819899080
- Cited by
- 122
- References
- 3
- FWCI
- 5.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.